GlaxoSmithKline plc (GSK) Reports Q4 EPS of GBP0.22

GlaxoSmithKline plc (NYSE: GSK) reported Q4 EPS of GBP0.22, versus GBP0.51 reported last year. Revenue for the quarter came in at GBP6.19 million, versus GBP6.91 million reported last year.

For earnings history and earnings-related data on GlaxoSmithKline plc (GSK) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• TotalEnergies strikes $1.8B deal with GIP on African assets
• Deutsche Bank Reiterates Buy Rating on Redcare Pharmacy NV (RDC:GR)